Vivos Therapeutics (VVOS) Institutional Ownership → 348 million Americans lives to END as we know it? (From The Oxford Club) (Ad) Free VVOS Stock Alerts $2.26 +0.08 (+3.67%) (As of 05/16/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Vivos Therapeutics (NASDAQ:VVOS)CurrentInstitutional OwnershipPercentage26.35%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$709.08KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$38.45M Get VVOS Insider Trade Alerts Want to know when executives and insiders are buying or selling Vivos Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data VVOS Institutional Buying and Selling by Quarter Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Vivos Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2024 Armistice Capital LLC57,000$709K0.0%N/A4.286% 1/16/2024Strategic Wealth Investment Group LLC128,789$1.60M0.2%-96.0%9.683% 4/24/2023Strategic Wealth Investment Group LLC3,219,705$1.10M0.2%N/A12.874% 4/20/2023Strategic Wealth Investment Group LLC232,737$1.10M0.2%N/A0.931% 4/18/2023 Godsey & Gibb Inc.92,999$32K0.0%N/A0.372% 2/10/2023 Bard Associates Inc.201,704$81K0.0%-6.9%0.806% Get the Latest News and Ratings for VVOS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vivos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/16/2022 SeaCrest Wealth Management LLC40,000$26K0.0%N/A0.174% 11/9/2022 Boston Partners78,454$51K0.0%-36.8%0.341% 11/4/2022 Russell Investments Group Ltd.365,901$236K0.0%-11.1%1.590% 10/24/2022 Perkins Capital Management Inc.56,500$37K0.0%-65.5%0.246% 7/29/2022 Perkins Capital Management Inc.163,800$211K0.2%+9.2%0.712% 7/29/2022 Russell Investments Group Ltd.411,589$530K0.0%-3.1%1.789% 5/10/2022 Boston Partners137,354$368K0.0%+27.2%0.597% 5/5/2022 Russell Investments Group Ltd.424,801$1.14M0.0%+39.2%1.846% 5/2/2022National Asset Management Inc.98,574$265K0.0%+24.4%0.428% 4/20/2022 Perkins Capital Management Inc.150,050$402K0.3%+10.3%0.652% 4/12/2022 Griffin Asset Management Inc.70,200$188K0.0%+63.3%0.305% 2/10/2022 Perkins Capital Management Inc.136,050$306K0.2%-7.1%0.591% 2/4/2022 Boston Partners108,015$243K0.0%+131.5%0.469% 2/3/2022 Cambridge Investment Research Advisors Inc.19,200$43K0.0%+60.0%0.083% 1/28/2022 Griffin Asset Management Inc.43,000$97K0.0%-13.1%0.187% 1/28/2022National Asset Management Inc.79,270$179K0.0%+55.5%0.344% 1/21/2022 Russell Investments Group Ltd.305,096$684K0.0%+554.0%1.326% 11/16/2021 Schonfeld Strategic Advisors LLC34,443$139K0.0%N/A0.151% 11/16/2021National Asset Management Inc.50,987$206K0.0%+46.9%0.224% 11/16/2021 Two Sigma Investments LP157,324$636K0.0%N/A0.690% 11/12/2021 WMS Partners LLC12,167$49K0.0%-27.0%0.053% 11/12/2021 Blueshift Asset Management LLC18,826$76K0.0%N/A0.083% 11/9/2021 BlackRock Inc.48,905$198K0.0%+255.8%0.214% 11/8/2021Avalon Investment & Advisory329,322$1.33M0.0%+73.6%1.444% 11/8/2021 Russell Investments Group Ltd.46,651$188K0.0%N/A0.205% 11/5/2021 Boston Partners46,651$188K0.0%N/A0.205% 11/2/2021 Cambridge Investment Research Advisors Inc.12,000$48K0.0%-68.0%0.053% 10/25/2021 Perkins Capital Management Inc.146,500$592K0.4%-9.8%0.642% 8/17/2021 Walleye Capital LLC150,000$743K0.0%N/A0.658% 8/16/2021 WMS Partners LLC16,667$153K0.0%N/A0.073% 8/16/2021 Archon Capital Management LLC215,000$1.06M0.1%N/A0.942% 8/13/2021 Renaissance Technologies LLC19,200$95K0.0%N/A0.084% 8/13/2021 Northern Trust Corp11,483$57K0.0%N/A0.050% 8/13/2021 Geode Capital Management LLC47,661$235K0.0%+285.0%0.209% [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now.8/13/2021 Vanguard Group Inc.383,891$1.90M0.0%N/A1.683% 8/12/2021 Bard Associates Inc.215,500$1.07M0.3%N/A0.945% 8/11/2021 Millrace Asset Group Inc.93,993$465K0.2%N/A0.412% 8/10/2021National Asset Management Inc.34,718$172K0.0%+21.9%0.152% 8/10/2021 Cambridge Investment Research Advisors Inc.37,551$186K0.0%N/A0.165% 7/30/2021Avalon Investment & Advisory189,739$939K0.0%+12.0%0.832% 5/21/2021 Citadel Advisors LLC15,846$105K0.0%N/A0.069% 5/18/2021 Millennium Management LLC78,898$524K0.0%-5.4%0.346% 5/18/2021 Citadel Advisors LLC15,846$105K0.0%N/A0.069% 5/14/2021Alpha Paradigm Partners LLC9,921$66K0.0%N/A0.054% 5/14/2021 K.J. Harrison & Partners Inc45,419$302K0.0%-50.3%0.249% 5/13/2021Avalon Investment & Advisory169,414$1.13M0.0%N/A0.930% 5/12/2021 Geode Capital Management LLC12,380$82K0.0%N/A0.068% 5/10/2021 Royce & Associates LP348,000$2.31M0.0%+16.0%1.911% 5/7/2021 BlackRock Inc.11,541$77K0.0%N/A0.063% 5/4/2021 Griffin Asset Management Inc.59,700$396K0.1%N/A0.328% 2/17/2021Jane Street Group LLC32,237$191K0.0%N/A0.182% 2/16/2021 Walleye Capital LLC74,500$440K0.0%N/A0.422% 2/9/2021 Perkins Capital Management Inc.20,000$118K0.1%N/A0.113% 2/8/2021 Royce & Associates LP300,000$1.77M0.0%N/A1.698% 2/8/2021 K.J. Harrison & Partners Inc91,322$540K0.1%N/A0.517% (Data available from 1/1/2016 forward) VVOS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VVOS shares? During the previous two years, the following institutional investors and hedge funds held shares of Vivos Therapeutics shares: Strategic Wealth Investment Group LLC ($1.60M), Armistice Capital LLC ($709K), Russell Investments Group Ltd. ($236K), Bard Associates Inc. ($81K), Boston Partners ($51K), Perkins Capital Management Inc. ($37K), and Godsey & Gibb Inc. ($32K).Learn more on VVOS's institutional investors. What percentage of Vivos Therapeutics stock is owned by institutional investors? 26.35% of Vivos Therapeutics stock is owned by institutional investors. Learn more on VVOS's institutional investor holdings. Which institutional investors have been buying Vivos Therapeutics stock? The following institutional investors have purchased Vivos Therapeutics stock in the last 24 months: Strategic Wealth Investment Group LLC ($3.45M), Godsey & Gibb Inc. ($93.00K), Armistice Capital LLC ($57K), SeaCrest Wealth Management LLC ($40K), and Perkins Capital Management Inc. ($13.75K). How much institutional buying is happening at Vivos Therapeutics? Institutional investors have bought a total of 3,656,191 shares in the last 24 months. This purchase volume represents approximately $32.04M in transactions. Which Vivos Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Vivos Therapeutics stock in the last 24 months: Strategic Wealth Investment Group LLC ($3.09M), Perkins Capital Management Inc. ($107.30K), Russell Investments Group Ltd. ($58.90K), Boston Partners ($45.69K), and Bard Associates Inc. ($15K). How much institutional selling is happening at Vivos Therapeutics? Institutional investors have sold a total of 3,317,804 shares in the last 24 months. This volume of shares sold represents approximately $42.26M in transactions. Related Companies: Vapotherm Institutional Ownership Intelligent Bio Solutions Institutional Ownership ProSomnus Institutional Ownership Avinger Institutional Ownership NeuroMetrix Institutional Ownership Venus Concept Institutional Ownership Sharps Technology Institutional Ownership Acutus Medical Institutional Ownership Biotricity Institutional Ownership Tenon Medical Institutional Ownership This page (NASDAQ:VVOS) was last updated on 5/17/2024 by MarketBeat.com Staff From Our Partners348 million Americans lives to END as we know it?The Oxford ClubCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceGold Set to EXPLODE!Gold Safe ExchangeInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaHow Biden has already won 2024Porter & CompanyA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.